ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 108 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $336 | -42.9% | 101,453 | -30.3% | 0.00% | – |
| Q1 2024 | $588 | -2.2% | 145,532 | -26.2% | 0.00% | – |
| Q4 2023 | $601 | +680.5% | 197,087 | +669.3% | 0.00% | – |
| Q3 2023 | $77 | +35.1% | 25,619 | +67.8% | 0.00% | – |
| Q2 2023 | $57 | -56.2% | 15,271 | -60.6% | 0.00% | – |
| Q1 2023 | $130 | +3.2% | 38,759 | +48.6% | 0.00% | – |
| Q4 2022 | $126 | -99.9% | 26,082 | -29.6% | 0.00% | – |
| Q3 2022 | $211,000 | -36.6% | 37,023 | -21.1% | 0.00% | – |
| Q2 2022 | $333,000 | -25.7% | 46,940 | -24.3% | 0.00% | – |
| Q1 2022 | $448,000 | – | 62,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |